4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-026873
General Counsel sold 1,048 shares at $23.35 ($24,471)
- General Counsel acquired 45,710 shares (other)
- General Counsel acquired 2,420 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wilson Martin General Counsel | 2024-05-14 | Option exercise | +2,420 | 21,100 | D: show line 1 in the form | ||
| Wilson Martin General Counsel | 2022-08-12 | Other acquisition | +28,763 | 49,863 | D: show line 2 in the form | ||
| Wilson Martin General Counsel | 2023-02-14 | Other acquisition | +16,947 | 66,810 | D: show line 3 in the form | ||
| Wilson Martin General Counsel | 2024-05-16 | Sale | −1,048 | $23.35 | $24,471 | 65,762 | D: show line 4 in the form |
| Open-market sales · 1,048 sh · avg $23.35 · $24,471 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Wilson Martin General Counsel | 2024-05-14 | Option exercise · Restricted Stock Units | −2,420 | 16,947 | D: show line 5 in the form | |||||
| Wilson Martin General Counsel | 2022-08-12 | Other disposition · Restricted Stock Units | −28,763 | 0 | D: show line 6 in the form | |||||
| Wilson Martin General Counsel | 2023-02-14 | Other disposition · Restricted Stock Units | −16,947 | 0 | D: show line 7 in the form |
Loading xslF345X05/form4.xml…